1. Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma
   Jingyang Li et al, 2022, Frontiers in Oncology CrossRef
2. GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer
   Renjie Yuan et al, 2023, Frontiers in Immunology CrossRef
3. Advances in glucosamine production from waste biomass and microbial fermentation technology and its applications
   Vishal Ahuja et al, 2021, Biomass Conversion and Biorefinery CrossRef
4. On a sugar high: Role of O-GlcNAcylation in cancer
   Giang Le Minh et al, 2023, Journal of Biological Chemistry CrossRef
5. GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer
   Yuying Zhou et al, 2024, Breast Cancer: Targets and Therapy CrossRef
6. The Hexosamine Biosynthesis Pathway: Regulation and Function
   Alysta Paneque et al, 2023, Genes CrossRef
7. GNPNAT1 Serves as a Prognostic Biomarker Correlated with Immune Infiltration and Promotes Cancer Cell Metastasis through Stabilization of Snai2 in Lung Adenocarcinoma
   Jinqi He et al, 2024, Biomedicines CrossRef
8. GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker
   Hao Hu et al, 2023, Oncology Reports CrossRef
9. GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer
   Yong Feng et al, 2022, Cancer Management and Research CrossRef
10. Identification of N-linked glycans recognized by WGA in saliva from patients with non-small cell lung cancer
    Fan Zhang et al, 2024, Carbohydrate Research CrossRef